Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant
Guilherme Rodrigues Fernandes Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

SARS-CoV-2’s Variants of Concern: A Brief Characterization
Aline Miranda Scovino, Elizabeth Chen Dahab, Gustavo Fioravanti Vieira, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
Zhonghao Chen, Ying Zhang, Meng Wang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4629-4641
Open Access | Times Cited: 33
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines
Moe H. Kyaw, Júlia Spinardi, Ling Zhang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 11
Humoral and cellular immunity against diverse SARS-CoV-2 variants
Changxu Chen, Xin Wang, Zeli Zhang
Journal of genetics and genomics/Journal of Genetics and Genomics (2023) Vol. 50, Iss. 12, pp. 934-947
Closed Access | Times Cited: 8
Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA genes
Cíntia Barros Santos-Rebouças, Cristina dos Santos Ferreira, Jeane de Souza Nogueira, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice
Dongdong Li, Lijun Bian, Lili Cui, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 8029-8042
Open Access | Times Cited: 2
Efficacy, Safety and Immunogenicity of Anti-SARS-CoV-2 Vaccines in Patients with Cirrhosis: A Narrative Review
Konstantina Toutoudaki, Melitini Dimakakou, Θεόδωρος Ανδρουτσάκος
Vaccines (2023) Vol. 11, Iss. 2, pp. 452-452
Open Access | Times Cited: 5
Viral coinfection in hospitalized patients during the COVID-19 pandemic in Southern Brazil: a retrospective cohort study
Jaqueline Rhoden, Andressa Taíz Hoffmann, Janaína Franciele Stein, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up
Camila Amormino Corsini, Priscila Fernanda da Silva Martins, Priscilla Soares Filgueiras, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated Vaccine
Benjamin J. Cowling, Samuel M. S. Cheng, Mario Martín-Sánchez, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 2, pp. 251-255
Open Access | Times Cited: 7
Homologous or Heterologous COVID-19 Booster Regimens Significantly Impact Sero-Neutralization of SARS-CoV-2 Virus and Its Variants
Rome Buathong, Taweewun Hunsawong, Supaporn Wacharapluesadee, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1321-1321
Open Access | Times Cited: 5
Mixed formulation of mRNA and protein‐based COVID‐19 vaccines triggered superior neutralizing antibody responses
Jialu Zhang, Qian He, Xujia Yan, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 4
Homologous or Heterologous COVID-19 Boosters Regimens Significantly Impact Sero-neutralization of SARS-CoV-2 Virus and Variants
Rome Buathong, Taweewun Hunsawong, Supaporn Wacharapluesadee, et al.
(2022)
Open Access | Times Cited: 3
Second booster dose improves antibody neutralization against BA.1, BA.5 and BQ.1.1 in individuals previously immunized with CoronaVac plus BNT162B2 booster protocol
Guilherme Rodrigues Fernandes Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Response Rate to the 3rd and 4th Doses of BNT162b2 Vaccine in Cancer Patients Administered with Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
(2023)
Open Access | Times Cited: 1
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 128-128
Open Access | Times Cited: 1
Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand
Kriangkrai Chawansuntati, Supachai Sakkhachornphop, Sayamon Hongjaisee, et al.
Vaccine X (2024) Vol. 18, pp. 100475-100475
Open Access
Registros de casos acumulados e novos de variantes de preocupação do COVID-19, Brasil, 2021-2022: Ômicron, Gamma e Delta
Adriana Ferreira Custódio, Linconl Agudo Oliveira Benito
Revista de Divulgação Científica Sena Aires (2022), pp. 548-564
Open Access
Page 1

Scroll to top